The CSC phenotype in HNSCC is characterized by the expression of several biomarkers, including the hyaluronic acid receptor CD44 as well as the ALDH isoforms ALDH1A1 and ALDH1A3 [32, 33]. This evidence concerns the gene ALDH1A3 and head and neck squamous cell carcinoma.